Librarian View
LEADER
03660cgm a2200721 a 4500
001
16084842
005
20211221230139.0
006
m o c
007
cr|cna|||a||||
007
vz|czazum
008
211204s2021 enk||| |o |s v|eng d
028
5
0
|a
5559
|b
Henry Stewart Talks
035
|a
(UkLoHST)4808
035
|a
(UkLoHST)HST5559
035
|a
16084842
040
|a
UkLoHST
|b
eng
|c
UkLoHST
100
1
|a
Raviglione, Mario C.
|4
spk
|0
http://id.loc.gov/authorities/names/n2001129513
245
1
4
|a
The End TB Strategy
|h
[electronic resource] :
|b
towards TB elimination, part 2 /
|c
Mario C. Raviglione.
246
3
|a
End TB Strategy : towards TB elimination, 2
260
|a
London :
|b
Henry Stewart Talks,
|c
2021.
300
|a
1 streaming video file (52 min.) :
|b
color, sound.
336
|a
two-dimensional moving image
|b
tdi
|2
rdacontent
337
|a
computer
|b
c
|2
rdamedia
338
|a
online resource
|b
cr
|2
rdacarrier
490
1
|a
Tuberculosis,
|x
2056-452X
500
|a
Animated audio-visual presentation with synchronized narration.
500
|a
Title from title frames.
505
0
|a
Contents: Tuberculosis -- The End TB Strategy -- Rapid molecular diagnostic testing -- Drug resistant TB -- Drug susceptibility testing -- TB and HIV -- Latent TB -- BCG vaccination -- Universal health -- TB and COVID-19.
506
|a
Access restricted by licensing agreement.
590
|a
Access is available to the Yale community.
610
2
0
|a
World Health Organization.
|0
http://id.loc.gov/authorities/names/n79059041
650
0
|a
COVID-19 (Disease)
|0
http://id.loc.gov/authorities/subjects/sh2020000570
650
0
|a
HIV infections
|x
Prevention.
|0
http://id.loc.gov/authorities/subjects/sh2009126442
650
0
|a
Multidrug-resistant tuberculosis.
|0
http://id.loc.gov/authorities/subjects/sh2007003767
650
0
|a
Tuberculosis
|x
Chemotherapy.
|0
http://id.loc.gov/authorities/subjects/sh85138409
650
0
|a
Tuberculosis
|x
Diagnosis.
|0
http://id.loc.gov/authorities/subjects/sh85138411
650
0
|a
Tuberculosis
|x
Prevention.
|0
http://id.loc.gov/authorities/subjects/sh85138425
650
0
|a
Antitubercular agents.
|0
http://id.loc.gov/authorities/subjects/sh85005784
650
0
|a
BCG vaccines.
|0
http://id.loc.gov/authorities/subjects/sh88000480
650
2
|a
Coinfection.
650
2
|a
Communicable Disease Control
|x
organization & administration.
650
2
|a
COVID-19.
650
2
|a
Disease Eradication.
650
0
|a
HIV infections
|x
prevention & control.
650
0
|a
International cooperation.
|0
http://id.loc.gov/authorities/subjects/sh85067385
650
2
|a
Latent Tuberculosis.
650
0
|a
Microbial sensitivity tests.
|0
http://id.loc.gov/authorities/subjects/sh85084774
650
2
|a
Molecular Diagnostic Techniques.
650
0
|a
Mycobacterium tuberculosis.
|0
http://id.loc.gov/authorities/subjects/sh85089186
650
2
|a
SARS-CoV-2.
650
0
|a
Tuberculosis
|x
drug therapy.
650
0
|a
Tuberculosis
|x
prevention & control.
650
2
|a
Tuberculosis, Multidrug-Resistant.
650
0
|a
Vaccination.
|0
http://id.loc.gov/authorities/subjects/sh85141709
650
0
|a
World health.
|0
http://id.loc.gov/authorities/subjects/sh85148199
830
0
|a
Henry Stewart talks.
|p
Biomedical & life sciences collection.
|p
Tuberculosis.
852
8
0
|z
Online resource
856
4
0
|y
Streaming video
|u
https://yale.idm.oclc.org/login?URL=https://hstalks.com/bs/4808/
902
|a
Yale Internet Resource
|b
Yale Internet Resource >> None|DELIM|16021010
905
|a
online resource
907
|a
2021-12-21T12:34:38.000Z
946
|a
DO NOT EDIT. DO NOT EXPORT.
953
|a
https://hstalks.com/bs/4808/